References

Does aneuploidy cause cancer?

10.1016/j.ceb.2006.10.002 · 2006 · External reference

The diverse consequences of aneuploidy

10.1038/s41556-018-0243-8 · 2019 · External reference

HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells

10.15252/embj.201488648 · 2014 · External reference

Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells

10.1126/science.1160058 · 2008 · External reference

Aneuploidy as a promoter and suppressor of malignant growth

10.1038/s41568-020-00321-1 · 2021 · External reference

Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells

10.1038/nbt.3178 · 2015 · External reference

Therapy-related myeloid neoplasms: when genetics and environment collide

10.1038/nrc.2017.60 · 2017 · External reference

Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis

10.7554/elife.07839 · 2015 · External reference

The genomic landscape of pediatric myelodysplastic syndromes

10.1038/s41467-017-01590-5 · 2017 · External reference

Genomic classification in acute myeloid leukemia

10.1056/nejmc1608739 · 2016 · External reference

Cytogenetic features in myelodysplastic syndromes

10.1007/s00277-008-0483-y · 2008 · External reference

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

10.1182/blood-2002-11-3343 · 2003 · External reference

International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data

10.1182/blood.2022015850 · 2022 · External reference

The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms

10.1038/s41375-022-01613-1 · 2022 · External reference

Characterization of large structural genetic mosaicism in human autosomes

10.1016/j.ajhg.2015.01.011 · 2015 · External reference

Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations

10.1038/s41586-018-0321-x · 2018 · External reference

Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis

10.1038/s41467-020-20565-7 · 2021 · External reference

Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis

10.1038/s41591-021-01411-9 · 2021 · External reference

Copy number alterations detected as clonal hematopoiesis of indeterminate potential

10.1182/bloodadvances.2017007922 · 2017 · External reference

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

10.1016/s1470-2045(16)30626-x · 2017 · External reference

The enigma of monosomy 7

10.1182/blood-2017-12-822262 · 2018 · External reference

The significance of CUX1 and chromosome 7 in myeloid malignancies

10.1097/moh.0000000000000699 · 2022 · External reference

Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets

10.1038/s41375-023-02003-x · 2023 · External reference

CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia

10.1182/blood-2012-04-426965 · 2013 · External reference

Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS

10.1182/blood-2017-10-810028 · 2018 · External reference

Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms

10.1182/blood.2020009195 · 2021 · External reference

Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia

10.1038/s41467-021-22750-8 · 2021 · External reference

A genetic map of the response to DNA damage in human cells

10.1016/j.cell.2020.05.040 · 2020 · External reference

SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice

10.15252/embj.2018100158 · 2018 · External reference

Genome-wide identification and characterization of novel factors conferring resistance to topoisomerase II poisons in cancer

10.1158/0008-5472.can-15-0380 · 2015 · External reference

A whole-genome CRISPR screen identifies a role of MSH2 in cisplatin-mediated cell death in muscle-invasive bladder cancer

10.1016/j.eururo.2018.10.040 · 2019 · External reference

DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells

10.1038/s41586-018-0670-5 · 2018 · External reference

Spindle assembly checkpoint inhibition can resensitize p53-null stem cells to cancer chemotherapy

10.1158/0008-5472.can-18-3024 · 2019 · External reference

A highly annotated database of genes associated with platinum resistance in cancer

10.1038/s41388-021-02055-2 · 2021 · External reference

Ribosomal protein S11 influences glioma response to TOP2 poisons

10.1038/s41388-020-1342-0 · 2020 · External reference

Genetic screens in human cells using the CRISPR-Cas9 system

10.1126/science.1246981 · 2014 · External reference

The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions

10.1002/pro.3978 · 2021 · External reference

Molecular signatures database (MSigDB) 3.0

10.1093/bioinformatics/btr260 · 2011 · External reference

Highly efficient genome editing of murine and human hematopoietic progenitor cells by CRISPR/Cas9

10.1016/j.celrep.2016.09.092 · 2016 · External reference

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

10.1038/sj.emboj.7600402 · 2004 · External reference

The roles of Polycomb repressive complexes in mammalian development and cancer

10.1038/s41580-021-00341-1 · 2021 · External reference

Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

10.1038/nm.4247 · 2017 · External reference

The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers

10.1128/mcb.01181-13 · 2013 · External reference

Multiple roles for the MLL/COMPASS family in the epigenetic regulation of gene expression and in cancer

10.1146/annurev-cancerbio-050216-034333 · 2017 · External reference

Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy

10.1016/j.celrep.2021.108751 · 2021 · External reference

Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia

10.1038/s41375-019-0402-3 · 2019 · External reference

Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation

10.1182/blood-2008-06-162263 · 2009 · External reference

Impaired function of primitive hematopoietic cells in mice lacking the mixed-lineage-leukemia homolog MLL5

10.1182/blood-2008-02-142638 · 2009 · External reference

MLL5 contributes to hematopoietic stem cell fitness and homeostasis

10.1182/blood-2008-05-159905 · 2009 · External reference

Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia

10.1200/jco.2010.31.1118 · 2011 · External reference

Recruitment of KMT2C/MLL3 to DNA damage sites mediates DNA damage responses and regulates PARP inhibitor sensitivity in cancer

10.1158/0008-5472.can-21-0688 · 2021 · External reference

The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer

10.15252/embr.201846821 · 2019 · External reference

DNA damage-induced HSPC malfunction depends on ROS accumulation downstream of IFN-1 signaling and bid mobilization

10.1016/j.stem.2016.08.007 · 2016 · External reference

Polycomb repressive complex 2 contributes to DNA double-strand break repair

10.4161/cc.25795 · 2013 · External reference

Global epigenetic analysis reveals H3K27 methylation as a mediator of double strand break repair

2021 · External reference

Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer

10.1016/j.cell.2018.03.022 · 2018 · External reference

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

10.1073/pnas.171321298 · 2001 · External reference

Murine models of acute myeloid leukemia

10.3389/fonc.2022.854973 · 2022 · External reference

Mouse hematopoietic stem cell identification and analysis

10.1002/cyto.a.20674 · 2009 · External reference

PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells

10.1182/blood-2018-05-850339 · 2018 · External reference

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

10.1182/blood-2011-12-397620 · 2012 · External reference

Genomic characterization of acute myeloid leukemia with aberrations of chromosome 7: a multinational cohort of 523 patients

10.1182/blood-2023-185627 · 2023 · External reference

Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas

10.1016/j.mrfmmm.2005.01.010 · 2005 · External reference

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

10.1182/blood.2022016867 · 2022 · External reference

PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy

10.1016/j.stem.2018.10.004 · 2018 · External reference

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

10.1038/nm.4210 · 2016 · External reference

Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner

10.1182/blood-2015-03-634428 · 2015 · External reference

LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia

10.1182/blood-2015-09-667808 · 2016 · External reference

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

10.1073/pnas.0506580102 · 2005 · External reference

The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing

10.1016/j.molcel.2013.12.005 · 2014 · External reference

Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island

2008 · External reference

Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG islands

10.1016/j.ccr.2011.09.012 · 2011 · External reference

Doxorubicin-induced DNA damage causes extensive ubiquitination of ribosomal proteins associated with a decrease in protein translation

10.1074/mcp.ra118.000652 · 2018 · External reference

Transcriptional responses to DNA damage

10.1016/j.dnarep.2019.05.002 · 2019 · External reference

Selective advantage of epigenetically disrupted cancer cells via phenotypic inertia

10.1016/j.ccell.2022.10.002 · 2023 · External reference

A stem cell molecular signature

10.1126/science.1073823 · 2002 · External reference

WikiPathways 2024: next generation pathway database

10.1093/nar/gkad960 · 2024 · External reference

Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin

10.1093/nar/gkn550 · 2008 · External reference

Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability

10.1242/jcs.215525 · 2018 · External reference

Protein-lysine methyltransferases G9a and GLP1 promote responses to DNA damage

10.1038/s41598-017-16480-5 · 2017 · External reference

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

10.1038/nature06494 · 2008 · External reference

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype

10.1038/nm.2054 · 2010 · External reference

Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc

10.1182/blood-2013-05-506568 · 2014 · External reference

A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions

10.1073/pnas.1206062109 · 2012 · External reference

Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells

10.1182/blood-2017-08-803353 · 2017 · External reference

Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress

10.1073/pnas.2105898119 · 2022 · External reference

Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential

10.1038/s41467-018-02858-0 · 2018 · External reference

Clonal hematopoiesis: mechanisms driving dominance of stem cell clones

2020 · External reference

Age-related clonal hematopoiesis associated with adverse outcomes

10.1056/nejmoa1408617 · 2014 · External reference

Somatic mutations and clonal hematopoiesis in aplastic anemia

10.1056/nejmoa1414799 · 2015 · External reference

Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly

10.1182/blood-2017-02-769869 · 2017 · External reference

Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects

10.1038/s41591-022-01883-3 · 2022 · External reference

Functional analyses of human LUC7-like proteins involved in splicing regulation and myeloid neoplasms

10.1016/j.celrep.2021.108989 · 2021 · External reference

Loss of LUC7L2 and U1 snRNP subunits shifts energy metabolism from glycolysis to OXPHOS

10.1016/j.molcel.2021.02.033 · 2021 · External reference

Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7

10.1016/j.ccr.2013.08.011 · 2013 · External reference